Kolexia
Taleb Cherifa Médecine interne
Taleb Cherifa
Médecine interne
Hôpital Jean Verdier
Bondy, France
37 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Tumeurs colorectales Sarcopénie Myélome multiple Tumeurs de la prostate Plasmocytome COVID-19

Collaborateurs

Voir plus
Landre Thierry
Landre Thierry
Hôpital Avicenne, Bobigny, France
Des Guetz Gaëtan
Des Guetz Gaëtan
Centre Hospitalier de Saint-Denis, Saint-Denis, France
Chouahnia Abdel Kader
Chouahnia Abdel Kader
Hôpital Avicenne, Bobigny, France
Chouaid Christos
Chouaid Christos
Centre Hospitalier Intercommunal Créteil, Créteil, France

Industries

Voir plus
Vifor
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Clinical benefit of anti-PD-1/PD-L1 plus chemotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic non-small cell lung cancer (NSCLC).
Journal of chemotherapy (Florence, Italy)   01 février 2024
1428P Clinical benefit of combination chemo-immunotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic NSCLC
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Prevalence of Four Sarcopenia Criteria in Older Patients with Cancer, and Their Predictive Value for 6-Month Mortality: The NutriAgeCancer National Prospective Cohort Study.
Nutrients   21 mars 2023
1613P Prevalence and predictive value for 6-month mortality of four criteria for assessment of sarcopenia in older patients with cancer: NutriAgeCancer national prospective cohort study
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
971P Is there a clinical benefit of nivolumab + ipilimumab in patients older than 75 years with advanced solid tumors?
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
1600P Suboptimal response to COVID-19 mRNA vaccines in older patients with cancer
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trials.
Cancer immunology, immunotherapy : CII   10 août 2021
Anti PD-(L)1 in KRAS mutant advanced nsclcs: A meta-analysis of randomized controlled trials.
2021 ASCO Annual Meeting I   28 mai 2021
Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-Analysis.
Cancers   28 mars 2021
First-line PD-1/PD-L1 inhibitor plus chemotherapy vs chemotherapy alone for negative or < 1% PD-L1-expressing metastatic non-small-cell lung cancers.
Journal of cancer research and clinical oncology   04 novembre 2019